프리마켓
로그인 회원가입
ADVB
ADVB
Advanced Biomed Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$14.36
-4.62 ▼ -24.34%
🌙 7월 28일 8:03 AM ET (한국 7/28 21:03)
$12.62
-1.74 ▼ -12.12%

어드밴스트바이오메드(ADVB) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$24M
스몰캡
P/E
90.2
고평가 구간
배당수익률
없음
52주 위치
52%
저점 +298% · 고점 -41%
애널리스트
-
B+
Fundamental health
vs. Diagnostics & Research
수익성
Top 1%
성장
Top 71%
밸류에이션
Top 2%
재무 안정
Top 28%
Index -P/E 90.2EPS (ttm) 0.16Insider Own 66.03%Shs Outstand 1.4MPerf Week 61.35%
Market Cap 0.02BForward P/E -EPS next Y -Insider Trans -Shs Float 0.6MPerf Month 187.78%
Enterprise Value 0.02BPEG -EPS next Q -Inst Own 0.08%Short Float 1.89%Perf Quarter 150.61%
Income 0.00BP/S -EPS this Y -Inst Trans -0.01%Short Ratio 0.01Perf Half Y 124.94%
Sales 0.00BP/B 68.9EPS next 5Y -ROA 59.9%Short Interest 0.01MPerf YTD 146.06%
Book/sh 0.21P/C 296.58EPS past 3/5Y 10.67% -12.01%ROE 84.61%52W High -40.73% ($24.23)Perf Year 43.66%
Cash/sh 0.05P/FCF -Sales past 3/5Y -ROIC 58.89%52W Low 297.78% ($3.61)Perf 3Y -
Dividend Est. -EV/EBITDA -EPS Y/Y TTM 271.18%Gross Margin -Volatility(W/M) 67.43% 24.09%Perf 5Y -
Dividend TTM -EV/Sales -Sales Y/Y TTM -Oper. Margin -ATR (14) 2.82Perf 10Y -
Dividend Ex-Date -Quick Ratio 7.38EPS Q/Q 69.15%Profit Margin -RSI (14) 66.77Recom -
Dividend Gr. 3/5Y -Current Ratio 7.38Sales Q/Q -SMA20 93.05% ($7.44)Beta -4.24Target Price -
Payout -Debt/Eq 0.07Earnings -SMA50 155.65% ($5.62)Rel Volume 0.24Prev Close $18.98
Employees 31LT Debt/Eq 0EPS/Sales Surpr. -SMA200 128.48% ($6.29)Avg Volume(3M) 1.79MPrice $14.36
IPO 2025/3/6Option/Short No/NoTrades 5339Volume 438,301Change -24.34%
Quarterly earnings trend SEC filings · USD
23.12
24.3
24.9
24.12
25.3
25.9
25.12
26.3
Revenue Net income 최근 분기: 매출 - · 순이익 $0M (YoY +65%)

📊 Advanced Biomed Inc (ADVB) Investment Analysis

What kind of company is Advanced Biomed Inc?

어드밴스트바이오메드(ADVB) 방어주
Healthcare · Diagnostics & Research
Small-Cap — Low Volume, High Volatility

🔬 is a microcap biotech company specializing in precision medicine diagnostics and research, headquartered in Tainan, Taiwan. Leveraging semiconductor microfluidic chip technology, the company detects and analyzes circulating tumor cells (CTCs) in the blood and develops precision medicine solutions, including its 3D cell culture platform A+PerfusC, which predicts responsiveness to anticancer treatment.

Learn more about Advanced Biomed Inc →
Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5207
Employees31people
IPO2025/03/06
Current Price$14.36 ≈ 19,673원
NASD · Taiwan

Key Events

예정된 이벤트가 없습니다

ADVB의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.

  • 실적 발표는 보통 분기마다 있습니다
  • 배당주는 연 1~4회 배당락일이 있습니다
전체 경제/실적 캘린더 보기 →

Is it profitable?

Financial health solid
Profitability — How efficiently it makes money
ROE
Annual return earned on shareholders' equity (15%+ is strong)
84.6%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -98.0% · Top tier
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
59.9%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -59.3% · Top tier
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
58.9%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -77.3% · Top tier
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.07
✓ Very low debt
My positionTop 25%
Low range Average High range
Diagnostics & Research Median 0.38
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
7.38
✓ 우수
My positionTop 5%
Low range Average High range
Diagnostics & Research Median 2.23
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
7.38
✓ 우수
My positionTop 5%
Low range Average High range
Diagnostics & Research Median 2.15
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Outlook data is insufficient

Analyst estimates and price targets have not been collected.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth
Mid-range within the industry
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+10.7%
평균
My positionMid-range
Low range Average High range
방어주 초소형주 Median 30.0% · Bottom 33%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
-12.0%
부진
My positionBottom 25%
Low range Average High range
방어주 초소형주 Median 16.4% · Bottom 24%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Outperformed the market by +28%p over the past year
ADVB +43.7% · S&P 500 +16.0%
Excess return vs. market (price-based, ex-dividends)
1-year basis
vs S&P 500
+27.6%p
ahead of the market
vs Health Care (XLV)
+23.9%p
ahead of the sector average
Rank among peers
1-year return Upper-Mid (30%) Based on 14 peers
Current position within 52-week range
Low (-297.8%p) High (-40.7%p)
Current price is 297.8% above the 52-week low and 40.7% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-48.5%
Annualized volatility
453.0%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢
Current diagnosis · 2026-07-27
Uptrend zone

Current price $14.36 above the midline ($7.43). Normal upward flow. Inside the Ichimoku cloud (neutral).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟢
Current diagnosis · 2026-07-27
Bullish momentum holding

MACD 2.588 > Signal 1.323 in positive zone + Hist positive (+1.264). Trend in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢
Current diagnosis · 2026-07-27
Bullish zone

RSI 66.7 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 49.1.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Pricier than peers in its industry
Pricey on Vs. Earnings·Vs. Assets
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Pricey
🏢 Vs. Assets Pricey
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
90.20x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Diagnostics & Research median 35.22x · Bottom 4% — expensive within the industry
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
68.90x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Diagnostics & Research median 3.37x · Bottom 1% — expensive within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Diagnostics & Research

Who owns it?

Ownership flow is positive
Institutional modest net selling -0.0% · Short interest light 1.9% · Short interest fell -4.3%p over the last 90 days
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
-0.0%
Institutions little change
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 0.1%
Retail-led
Healthcare 초소형주 Median 14.2%
🧑‍💼 Insiders 66.0%
Founder/management large holders (strong skin-in-the-game)
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 33.9%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
1.9%
Low — limited short-side pressure
Healthcare 초소형주 Median 3.9%
Past 90 days 📉 -4.3%p decrease
Short interest days to cover
0.0 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 1.4M주
Float (tradable shares) 0.6M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
ADVB ADVB This Stock
$23.7M90.2 68.9 84.61% - -24.3%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 어드밴스트바이오메드(ADVB)?

어드밴스트바이오메드(ADVB) belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is the market cap of ADVB?

The market cap of ADVB is approximately $24M, ranking 5,207 within its sector.

What is the P/E ratio of ADVB?

ADVB has a P/E ratio of approximately 90.2x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for ADVB?

ADVB has recorded a 52-week high of $24.23 and a low of $3.61.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.